logologo
QuantliQuantli

Erasca Inc

ERAS

NASDAQ

Biotechnology

$18.38

USD

+0.52 (+2.91%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $6.25B

Volume 2.5M

Price Target

$16.00$22.00

USD

The 3 analysts offering 1-year price forecasts have a max estimate of $22.00 and a min estimate of $16.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$19.67

-$3.0 vs prior

Implied Upside

+7.0%

-16.5% vs prior

Analyst Covering

3

-4 vs prior period

Consensus

Hold

Declined vs prior

Signal Quality

Consensus Freshness

30%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$1.33 Gap

Median $21.00 vs avg $19.67 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Hold

1 Buy

2 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

2

Sell

0

Strong Sell

0

3 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Andres Y. Maldonado

HC Wainwright & Co.

Buy

Maintained

3 days ago

Plus
Plus
Plus

Sean Laaman

Morgan Stanley

Hold

Maintained

3 weeks ago

Plus
Plus
Plus

Alec Stranahan

B of A Securities

Hold

Upgraded

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

TVTX

Travere Therapeutics Inc

$62.14

+1.2%

ACAD

ACADIA Pharmaceuticals Inc

$28.24

-0.5%

SRRK

Scholar Rock Holding Corp

$52.52

-1.0%

CAI

Caris Life Sciences Inc

$21.80

-1.7%

MIRM

Mirum Pharmaceuticals Inc

$100.64

+1.9%

DYN

Dyne Therapeutics, Inc

$25.70

-1.0%

PTCT

PTC Therapeutics Inc

$71.70

-0.4%

CGON

CG Oncology Inc

$75.03

+0.4%

COGT

Cogent Biosciences Inc

$37.93

+1.7%

DNTH

Dianthus Therapeutics Inc

$115.96

+5.8%